FLT3 mutations and AML: Recent findings, laboratory considerations, and clinical implications
*NEW* Free for members and $29 for nonmembers
New checkout process! Please view the video for assistance.
This interactive live webinar is part 14 of the Emerging and Evolving Biomarkers Series.
Description:
Join this webinar on FLT3-mutated AML, focusing on current therapy, diagnostic testing, and the use of PCR-NGS MRD assays in the clinical management of these patients.
Learning Objectives:
- Understand the use and limitations
of the current companion diagnostic test for FLT3 inhibitors in clinical use
today.
- Explain the role of different FLT3
inhibitors as incorporated into induction, consolidation, and maintenance
therapy per NCCN guidelines.
- Discuss recent findings from
randomized clinical trials incorporating high-sensitivity PCR-NGS MRD testing
for FLT3-ITD mutations.
 |
 |
|---|---|
|
Speaker:
Mark Levis, MD, PhD John Hopkins Medicine |
Moderator:
Jennifer Bynum, MD |
Duration: 1 Hour
Live webinar: September 28, 2023
- Click the "Register Now" Button
- Log in using your AMP credentials. If you do not have an AMP account, Create a FREE account.
- Complete the checkout process, Free for members and $29 for nonmembers
- Click on "My Courses" and complete the registration for the live webinar
- Complete the "Demographic questionnaire for Emerging and Evolving Biomarkers Series" before the webinar date. You will only need to do this once for the entire series.
Continuing Education Credit Information
CME credit: 1.0CMLE credit: 1.0
Last day to claim credit: December 31, 2024
Accreditation Statements
AMA PRA Category 1 Credit(s)™
This
activity has been planned and implemented in accordance with the
Essential Areas and policies of the Accreditation Council for Continuing
Medical Education through the joint providership of American Society
for Clinical Pathology (ASCP) and Association for Molecular Pathology
(AMP). The American Society for Clinical Pathology (ASCP) is accredited
by the ACCME to provide continuing medical education for physicians.
The ASCP designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
CMLE
This continuing medical laboratory education activity is recognized by the American Society for Clinical Pathology for 1.0 hours of CMLE credit. ASCP CMLE credit hours are acceptable for the
ASCP Board of Certification (BOC) Certification Maintenance Program (CMP). CMLE credit hours meet the continuing education requirements for the ASCP Board of Certification Credential Maintenance Program (CMP) and state relicensure requirements
for laboratory personnel. Participants should claim only the credit commensurate with the extent of their participation in the activity.
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentation.